The prophylactic effect of low doses of human leukocyte interferon (HuIFN-α) against infection with rhinovirus was measured in double-blind, placebo-controlled studies with volunteer subjects. An antihistamine (chlorpheniramine) was given before administration of single or multiple doses of HuIFN-α by saturated cotton pledget or by aerosol; volunteers were then challenged with rhinovirus. When the results for all groups were combined, a lower frequency of respiratoy illness was demonstrated in the HuIFN-α-treated volunteers (20 of 39 vs. 11 of 38, P < 0.05). A significant improvement in mean symptom scores was found only in the volunteers who received HuIFN-α by cotton pledget. The total numbers of isolates of rhinovirus and seroconversions were similar for HuIFN-α-treated and control volunteers. No significant side effects were noted in the HuIFN-α-treated volunteers. Higher concentrations or improved methods of delivery of HuIFN-α will be necessary for improving the clinical efficacy of HuIFN-α against viral infections in the respiratory system.
|Original language||English (US)|
|Number of pages||5|
|Journal||Journal of Infectious Diseases|
|State||Published - Apr 1982|
ASJC Scopus subject areas
- Immunology and Allergy
- Infectious Diseases